Page last updated: 2024-08-16

salmeterol xinafoate and Tremor

salmeterol xinafoate has been researched along with Tremor in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA1
Decramer, ML; Hanania, NA; Lötvall, JO; Yawn, BP1
Grove, A; Lipworth, BJ1
Calderaro, F; Califano, C; Cazzola, M; Di Pema, F; Donner, CF; Matera, MG; Vinciguerra, A1
Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; McLachlan, CR; McRae, W; Taylor, DR1
Dahl, R; Earnshaw, JS; Palmer, JB1
Svedmyr, N; Ullman, A1

Reviews

1 review(s) available for salmeterol xinafoate and Tremor

ArticleYear
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.
    International journal of chronic obstructive pulmonary disease, 2013, Volume: 8

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Blood Glucose; Cough; Ethanolamines; Formoterol Fumarate; Headache; Humans; Indans; Nasopharyngitis; Potassium; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Tract Infections; Salmeterol Xinafoate; Spasm; Tachycardia; Tremor

2013

Trials

6 trial(s) available for salmeterol xinafoate and Tremor

ArticleYear
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:2

    Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Ipratropium; Male; Middle Aged; Myocardial Ischemia; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Salmeterol Xinafoate; Tremor

2008
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Thorax, 1996, Volume: 51, Issue:1

    Topics: Adrenergic Agents; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Ethanolamines; Exercise; Female; Formoterol Fumarate; Heart Rate; Humans; Male; Potassium; Propranolol; Salmeterol Xinafoate; Single-Blind Method; Tremor

1996
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    European journal of clinical pharmacology, 1999, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Terbutaline; Time Factors; Tremor

1999
The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2000, Volume: 37, Issue:8

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Amino Acid Sequence; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Electrocardiography; Female; Forced Expiratory Volume; Heart Rate; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Receptors, Adrenergic, beta; Salmeterol Xinafoate; Tremor

2000
Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.
    The European respiratory journal, 1991, Volume: 4, Issue:10

    Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Hemodynamics; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Tremor

1991
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Thorax, 1988, Volume: 43, Issue:9

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Muscles; Peak Expiratory Flow Rate; Random Allocation; Salmeterol Xinafoate; Time Factors; Tremor

1988